THE GIBSON GROUP, LLC for ENDO PHARMACEUTICALS INC.
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
Oversight of implementation of the America Invents Act. Issues relating to patent settlements. Patent reform. Issues relating to misuse of the inter pares review process.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSEPH H GIBSON | — |
Health Issues HCR
Issues relating to prescription drug abuse. Issues relating to incentives for tamper-resistant formulations. Issues relating to FDA approvals of new drugs and generic drugs. Issues related to the FDA. Issues related to Opioids. Issues relating to Medicare Part D rebates. Issues relating to the labeling of generic drugs. Issues relating to CDC guidance for prescribing opioids. Issues relating to products containing high doses of acetaminophen. Issues relating to the labeling of generic drugs. Issues relating to removal of FDA unapproved products from the market. Opioid abuse legislation. Issues relating to prescription drug pricing. Issues relating to the removal of Opana ER from the market. Issues relating to illegal marketing of phenobarbital. Issues related to FDA approval of adrenaline. Issues relating to drug compounding.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSEPH H GIBSON | Counsel for Legislative & Intergovernmental Affairs Anti-Trust Division, DOJ 2001-2002; Chief Antitrust Counsel, House Judiciary Committee 1997-2001; Counsel, House Judiciary Committee 1995-1997 |
Taxation/Internal Revenue Code TAX
Issues relating to incentives for life sciences research. Tax treatment of inverted companies. Tax issues in mergers and acquisitions of US firms.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSEPH H GIBSON | — |
Torts TOR
Issues relating to Mass Torts and Class Action Reform.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSEPH H GIBSON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.